Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Multiple Sclerosis

  Free Subscription


22.12.2025

1 Can J Neurol Sci
1 J Neuroimmunol
2 J Neurol
1 J Neurol Sci
1 Mult Scler
3 Neurology
1 Rev Neurol (Paris)


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Can J Neurol Sci

  1. BHATELE P, Prabhu AN, Pai AR
    Impact of Autoantibody Status on Visual Outcomes in Severe Optic Neuritis Patients Without Multiple Sclerosis.
    Can J Neurol Sci. 2025 Dec 16:1-7. doi: 10.1017/cjn.2025.10474.
    PubMed         Abstract available


    J Neuroimmunol

  2. ULUC F, Ceylan D, Turkoglu SA
    Pilot analysis of Chitinase-3-like protein 1 and soluble Syndecan-1 CSF levels as potential biomarkers in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2025;411:578836.
    PubMed         Abstract available


    J Neurol

  3. KONITSIOTI AM, Schweitzer F, Johannis W, Steffen F, et al
    Serum neurofilament light chain as a biomarker of disease control in multiple sclerosis: a real-world cross-sectional analysis of therapeutic regimens.
    J Neurol. 2025;273:34.
    PubMed         Abstract available

  4. TAN H, Yin Z, Zhangbao J, Li X, et al
    Retinal nerve fiber layer thinning in multiple sclerosis: clinical implications, cognitive associations, and effects of disease-modifying therapies.
    J Neurol. 2025;273:25.
    PubMed         Abstract available


    J Neurol Sci

  5. FUCHS L, Avizov R, Karni A, Golan M, et al
    Siponimod enhances brain-derived neurotrophic factor secretion from immune cells in multiple sclerosis: A longitudinal study.
    J Neurol Sci. 2025;480:125699.
    PubMed         Abstract available


    Mult Scler

  6. RATTI S, Eke H, Cantarutti A, Bonn SE, et al
    Mediterranean diet and risk of multiple sclerosis: A prospective cohort study.
    Mult Scler. 2025 Dec 15:13524585251396408. doi: 10.1177/13524585251396408.
    PubMed         Abstract available


    Neurology

  7. BOS L, Wink AM, Cole JH, Strijbis EMM, et al
    Association of Brain Age With Physical Disability and Cognitive Impairment in People With Multiple Sclerosis of the Same Age.
    Neurology. 2026;106:e214527.
    PubMed         Abstract available

  8. SPAIN RI, Paz Soldan MM, Freedman MS, Repovic P, et al
    Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.
    Neurology. 2026;106:e214454.
    PubMed         Abstract available

  9. BRIGGS FBS, Amezcua L
    Alpha Lipoic Acid in Multiple Sclerosis: It's All in the Details.
    Neurology. 2026;106:e214578.
    PubMed        


    Rev Neurol (Paris)

  10. MOULIGNIER A, Guillaume J, Pourcher V, Maillart E, et al
    Impact of HIV on disability progression in multiple sclerosis: An observational retrospective matched cohort study.
    Rev Neurol (Paris). 2025 Dec 15:S0035-3787(25)00650.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.